5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.81▼ | 0.79▲ | 0.78▲ | 0.83▼ | 0.69▲ |
MA10 | 0.80▲ | 0.78▲ | 0.79▲ | 0.75▲ | 0.64▲ |
MA20 | 0.78▲ | 0.79▲ | 0.82▼ | 0.67▲ | 0.57▲ |
MA50 | 0.79▲ | 0.82▼ | 0.78▲ | 0.60▲ | 1.05▼ |
MA100 | 0.81▼ | 0.74▲ | 0.68▲ | 0.58▲ | 3.42▼ |
MA200 | 0.79▲ | 0.67▲ | 0.64▲ | 0.79▲ | 4.79▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | 0.003▲ | -0.006▼ | 0.020▲ | 0.112▲ |
RSI | 55.787▲ | 51.034▲ | 50.972▲ | 62.680▲ | 48.764▼ |
STOCH | 78.474 | 65.717 | 46.959 | 79.438 | 66.459 |
WILL %R | -22.993▲ | -22.993▲ | -49.732 | -33.888 | -25.890 |
CCI | 62.781 | 105.367▲ | 31.220 | 52.858 | 152.113▲ |
Thursday, July 10, 2025 01:00 PM
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced a significant surge in demand for its lead product, YCANTH®, in the second quarter of 2025, reporting 13,434 dispensed ...
|
Wednesday, July 09, 2025 04:01 AM
Company reports sequential quarterly growth of 32.8% over Q1 2025 with a record 13,434 YCANTH® dispensed applicator units in Q2 2025 – – Company reports receipt of $8 million milestone payment from ...
|
Wednesday, July 02, 2025 01:00 AM
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced an amended collaboration and licensing agreement with Torii Pharmaceutical Co. Ltd. to initiate a global Phase 3 clinical ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
14/07/25 | 0.766 | 0.8305 | 0.72 | 0.8053 | 472,511 |
11/07/25 | 0.85 | 0.895 | 0.7765 | 0.8066 | 445,079 |
10/07/25 | 0.815 | 0.95 | 0.80 | 0.8725 | 623,014 |
09/07/25 | 0.882 | 0.95 | 0.7671 | 0.819 | 1,351,659 |
08/07/25 | 0.83 | 0.8724 | 0.7901 | 0.8619 | 521,831 |
07/07/25 | 0.71 | 0.8393 | 0.70 | 0.83 | 675,797 |
03/07/25 | 0.659 | 0.7218 | 0.6474 | 0.7067 | 484,602 |
02/07/25 | 0.62 | 0.659 | 0.5811 | 0.6483 | 1,030,297 |
01/07/25 | 0.54 | 0.6409 | 0.53 | 0.601 | 3,707,663 |
30/06/25 | 0.53 | 0.548 | 0.53 | 0.5301 | 168,424 |
|
|
||||
|
|
||||
|
|